The need for a protocol

Our interpretation of recent scientific evidence leads us to conclude that biotechnological safety is a high political priority. Without comprehensive international regulation the potential for released biotechnological LMOs to cause ecological disruption is a significant risk to global biological diversity. The CBD is the only existing international agreement that provides a contemporary and accurate scientific context for the development of a bio-safety agreement.

By creating a model of high minimum standards for national and regional regulation, a bio-safety protocol would ensure that biotechnological activities carried out under the jurisdiction of a state do not cause damage to the environment of other states or areas beyond their national jurisdiction. This is in accordance with the Principle of the CBD, set forth in article 3. Governments arguing that there is no risk in transfers of LMOs resulting from biotechnology have often themselves had legally binding rules on bio-safety for many years and have followed those rules. However, because the products of biotechnology can have effects that cross political boundaries, separate national regulatory systems are not enough.

Legally, politically and economically, a protocol is needed to:

It is critical that future meetings to negotiate a bio-safety protocol discuss the development of means to enforce it.


Next section/References

First page/Table of contents

BIO-SAFETY HOME PAGE